Radiofrequency ablation induces tumor cell dissemination in a mouse model of hepatocellular carcinoma

被引:1
作者
Zhuang, Bowen [1 ]
Zhu, Xi [2 ]
Lin, Jinhua [1 ]
Zhang, Fuli [3 ,4 ]
Qiao, Bin [1 ]
Kang, Jihui [5 ]
Xie, Xiaohua [1 ]
Wei, Xunbin [3 ,4 ,6 ,7 ]
Xie, Xiaoyan [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Inst Diagnost & Intervent Ultrasound, Dept Med Ultrason, Guangzhou 510080, Peoples R China
[2] Kunming Med Univ, Biomed Engn Res Ctr, Kunming, Peoples R China
[3] Shanghai Jiao Tong Univ, Medx Res Inst, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China
[6] Peking Univ, Biomed Engn Dept, Beijing 100081, Peoples R China
[7] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing 100142, Peoples R China
关键词
Ethanol; Hepatocellular carcinoma; Lung neoplasms; Neoplastic cells (circulating); Radiofrequency ablation; PROGNOSTIC-FACTORS; CANCER; RESECTION; SURVIVAL; CLUSTERS; THERAPY; RELEASE; SURGERY;
D O I
10.1186/s41747-023-00382-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundWe tested the hypothesis that radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) promotes tumor cell release and explored a method for reducing these effects.MethodsA green fluorescent protein-transfected orthotopic HCC model was established in 99 nude mice. In vivo flow cytometry was used to monitor circulating tumor cell (CTC) dynamics. Pulmonary fluorescence imaging and pathology were performed to investigate lung metastases. First, the kinetics of CTCs during the periablation period and the survival rate of CTCs released during RFA were investigated. Next, mice were allocated to controls, sham ablation, or RFA with/without hepatic vessel blocking (ligation of the portal triads) for evaluating the postablation CTC level, lung metastases, and survival over time. Moreover, the kinetics of CTCs, lung metastases, and mice survival were evaluated for RFA with/without ethanol injection. Pathological changes in tumors and surrounding parenchyma after ethanol injection were noted. Statistical analysis included t-test, ANOVA, and Kaplan-Meier survival curves.ResultsCTC counts were 12.3-fold increased during RFA, and 73.7% of RFA-induced CTCs were viable. Pre-RFA hepatic vessel blocking prevented the increase of peripheral CTCs, reduced the number of lung metastases, and prolonged survival (all p <= 0.05). Similarly, pre-RFA ethanol injection remarkably decreased CTC release during RFA and further decreased lung metastases with extended survival (all p <= 0.05). Histopathology revealed thrombus formation in blood vessels after ethanol injection, which may clog tumor cell dissemination during RFA.ConclusionRFA induces viable tumor cell dissemination, and pre-RFA ethanol injection may provide a prophylactic strategy to reduce this underestimated effect.Relevance statementRFA for HCC promotes viable tumor cell release during ablation, while ethanol injection can prevent RFA induced tumor cell release.Key points center dot RFA induced the release of viable tumor cells during the ablation procedure in an animal model.center dot Hepatic vessel blocking can suppress tumor cells dissemination during RFA.center dot Ethanol injection can prevent RFA-induced tumor cell release, presumably because of the formation of thrombosis.Key points center dot RFA induced the release of viable tumor cells during the ablation procedure in an animal model.center dot Hepatic vessel blocking can suppress tumor cells dissemination during RFA.center dot Ethanol injection can prevent RFA-induced tumor cell release, presumably because of the formation of thrombosis.Key points center dot RFA induced the release of viable tumor cells during the ablation procedure in an animal model.center dot Hepatic vessel blocking can suppress tumor cells dissemination during RFA.center dot Ethanol injection can prevent RFA-induced tumor cell release, presumably because of the formation of thrombosis.
引用
收藏
页数:13
相关论文
共 34 条
  • [1] Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
    Aceto, Nicola
    Bardia, Aditya
    Miyamoto, David T.
    Donaldson, Maria C.
    Wittner, Ben S.
    Spencer, Joel A.
    Yu, Min
    Pely, Adam
    Engstrom, Amanda
    Zhu, Huili
    Brannigan, Brian W.
    Kapur, Ravi
    Stott, Shannon L.
    Shioda, Toshi
    Ramaswamy, Sridhar
    Ting, David T.
    Lin, Charles P.
    Toner, Mehmet
    Haber, Daniel A.
    Maheswaran, Shyamala
    [J]. CELL, 2014, 158 (05) : 1110 - 1122
  • [2] Angonese C, 2006, GUT, V55, P435
  • [3] SnapShot: Circulating Tumor Cells
    Dive, Caroline
    Brady, Ged
    [J]. CELL, 2017, 168 (04)
  • [4] European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
  • [5] Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by In Vivo Flow Cytometry Assesses Resection on Metastasis
    Fan, Zhi-Chao
    Yan, Jun
    Liu, Guang-Da
    Tan, Xiao-Ying
    Weng, Xiao-Fu
    Wu, Wei-Zhong
    Zhou, Jian
    Wei, Xun-Bin
    [J]. CANCER RESEARCH, 2012, 72 (10) : 2683 - 2691
  • [6] In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
    He, Wei
    Wang, Haifeng
    Hartmann, Lynn C.
    Cheng, Ji-Xin
    Low, Philip S.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (28) : 11760 - 11765
  • [7] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]
  • [8] Unique Localization of Circulating Tumor Cells in Patients With Hepatic Metastases
    Jiao, Long R.
    Apostolopoulos, Christos
    Jacob, Jimmy
    Szydlo, Richard
    Johnson, Natalia
    Tsim, Nicole
    Habib, Nagy A.
    Coombes, R. Charles
    Stebbing, Justin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6160 - 6165
  • [9] Real-time monitoring of circulating tumor cell release during tumor manipulation using in vivo photoacoustic and fluorescent flow cytometry
    Juratli, Mazen A.
    Sarimollaoglu, Mustafa
    Siegel, Eric R.
    Nedosekin, Dmitry A.
    Galanzha, Ekaterina I.
    Suen, James Y.
    Zharov, Vladimir P.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (08): : 1207 - 1215
  • [10] Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance
    Kang, Tae Wook
    Lim, Hyo Keun
    Lee, Min Woo
    Kim, Young-sun
    Rhim, Hyunchul
    Lee, Won Jae
    Gwak, Geum-Youn
    Paik, Yong Han
    Lim, Ho Yeong
    Kim, Min Ji
    [J]. RADIOLOGY, 2015, 276 (01) : 274 - 285